Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

This valuable study uses robust time-dependent microscopy assays to show that during HIV-1 infection, the viral accessory protein Vif causes cell cycle arrest during metaphase and not G2/M as ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

INPP4B works with two other proteins—PIKfyve and TRPML-1—to modify the lysosome's surface structure and alter local calcium levels so that the organelle is propelled to the cell periphery.

It takes time after the human immunodeficiency virus (HIV) enters your body before a test can detect it, and this period of time is known as the HIV window period. If you take a test during your ...

Capital structure describes the mix of a firm's long-term capital—a mix of debt and equity—that it uses to fund its ongoing operations and future growth. A company's capital structure is ...

Copyright 2024 The Associated Press. All Rights Reserved. In this photo provided by Johns Hopkins Medicine, Dr. Dorry Segev, right, performs the first U.S. transplant ...

Vaccines activate our immune system to fight a viral infection by producing neutralizing antibodies that bind and prevent a virus from infecting our cells. Vaccines contain ... to mimic the native ...

Additional criteria included a CD4+ cell count of at least 200 cells per microliter, active antiretroviral therapy, and an HIV RNA level of less than 50 copies per milliliter. Exclusion criteria ...

Study in @NEJM (bit.ly/3A11pkU) led by @HopkinsMedicine provides strong evidence that #HIV-to-HIV transplants are as safe & effective as transplants using organs donated by people w/o HIV. @HopkinsTRC ...

RIO DE JANEIRO — Brazilian health officials are scrambling to explain how six transplant patients in the country’s well-regarded public health system received organs infected with HIV — and ...